The Center for Diabetes and Endocrine Care
Hollywood, Florida, United States
Endocrinologist in Hollywood, Florida
3107 Stirling Rd #300, Davie, FL 33312
About The Center for Diabetes and Endocrine Care
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at The Center for Diabetes and Endocrine Care
During the past decade, The Center for Diabetes and Endocrine Care conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on
average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer
2001-03-01
2008-11-01
Completed
S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer
2006-04-01
Unknown status
500
Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer
2005-07-01
2021-12-13
Completed
6,927
Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
2009-02-04
2018-06-03
Completed
233
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
2009-07-09
2019-10-04
Completed
2,840
A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy
2013-07-01
2014-06-01
Terminated
18
Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer
2014-01-01
2019-12-01
Completed
310
A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)
2015-06-23
2021-08-31
Completed
902
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Center for Diabetes and Endocrine Care" #1 sponsor was "Corcept Therapeutics" with 4 trials, followed by "Eli Lilly and Company" with 4 trials
sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Gan and Lee Pharmaceuticals, USA" with 3 trials sponsored and "Cortendo AB"
with 3 trials sponsored. Other sponsors include 16 different institutions and
companies that sponsored additional 20 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Center for Diabetes and Endocrine Care"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at The Center for Diabetes and Endocrine Care
According to Clinical.Site data, the most researched conditions in "The Center for Diabetes and Endocrine Care" are
"Diabetes Mellitus, Type 2" (6 trials), "Diabetes Mellitus, Type 1" (5 trials), "Type 2 Diabetes Mellitus" (5 trials), "Cushing's Syndrome" (4 trials) and "Diabetes" (2 trials). Many other conditions were trialed in "The Center for Diabetes and Endocrine Care" in a lesser frequency.
Clinical Trials Intervention Types at The Center for Diabetes and Endocrine Care
Most popular intervention types in "The Center for Diabetes and Endocrine Care" are "Drug" (31 trials), "Biological" (4 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Insulin Degludec" (4 trials), "Gan & Lee Insulin Glargine Injection" (2 trials), "Insulin Glargine" (2 trials) and "Insulin Lispro" (2 trials). Other intervention names were less common.
Clinical Trials Genders at The Center for Diabetes and Endocrine Care
The vast majority of trials in "The Center for Diabetes and Endocrine Care" are
35 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at The Center for Diabetes and Endocrine Care
Currently, there are NaN active trials in "The Center for Diabetes and Endocrine Care".
undefined are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 28 completed trials in The Center for Diabetes and Endocrine Care,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in The Center for Diabetes and Endocrine Care, 1 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 21 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".